IDH1 and central nervous system cancer: In addition, we also analyzed the mutation frequency of tyrosine metabolizing enzymes in low‐grade glioma and GBM and found that the mutation frequency of tyrosine metabolizing enzymes was much lower than that of IDH (Figure 4B).